Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Pharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteers.

Chinh NT, Quang NN, Anh CX, Thanh NX, Dai B, Birrell GW, Chavchich M, Edstein MD.

Antimicrob Agents Chemother. 2011 Sep;55(9):4412-5. doi: 10.1128/AAC.00365-11. Epub 2011 Jul 5.

2.

Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

Noedl H, Krudsood S, Chalermratana K, Silachamroon U, Leowattana W, Tangpukdee N, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Sriwichai S, Rowan J, Bhattacharyya H, Ohrt C, Knirsch C.

Clin Infect Dis. 2006 Nov 15;43(10):1264-71. Epub 2006 Oct 12.

PMID:
17051490
3.

Azithromycin for treating uncomplicated malaria.

van Eijk AM, Terlouw DJ.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006688. doi: 10.1002/14651858.CD006688.pub2. Review.

PMID:
21328286
5.

Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam.

Nguyen DV, Nguyen QP, Nguyen ND, Le TT, Nguyen TD, Dinh DN, Nguyen TX, Bui D, Chavchich M, Edstein MD.

Antimicrob Agents Chemother. 2009 Aug;53(8):3534-7. doi: 10.1128/AAC.01717-08. Epub 2009 Jun 15.

6.

Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.

Simpson JA, Agbenyega T, Barnes KI, Di Perri G, Folb P, Gomes M, Krishna S, Krudsood S, Looareesuwan S, Mansor S, McIlleron H, Miller R, Molyneux M, Mwenechanya J, Navaratnam V, Nosten F, Olliaro P, Pang L, Ribeiro I, Tembo M, van Vugt M, Ward S, Weerasuriya K, Win K, White NJ.

PLoS Med. 2006 Nov;3(11):e444.

7.

Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers.

Davis TM, England M, Dunlop AM, Page-Sharp M, Cambon N, Keller TG, Heidecker JL, Ilett KF.

Antimicrob Agents Chemother. 2007 Mar;51(3):1099-101. Epub 2006 Dec 18.

8.

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.

Ali S, Najmi MH, Tarning J, Lindegardh N.

Malar J. 2010 Oct 11;9:275. doi: 10.1186/1475-2875-9-275.

9.

A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand.

Krudsood S, Silachamroon U, Wilairatana P, Singhasivanon P, Phumratanaprapin W, Chalermrut K, Phophak N, Popa C.

Southeast Asian J Trop Med Public Health. 2000 Dec;31(4):801-7.

PMID:
11414432
10.

Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.

Tan B, Naik H, Jang IJ, Yu KS, Kirsch LE, Shin CS, Craft JC, Fleckenstein L.

Malar J. 2009 Dec 18;8:304. doi: 10.1186/1475-2875-8-304.

11.

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.

McGready R, Stepniewska K, Ward SA, Cho T, Gilveray G, Looareesuwan S, White NJ, Nosten F.

Eur J Clin Pharmacol. 2006 May;62(5):367-71. Epub 2006 Mar 22.

PMID:
16552504
12.

Population pharmacokinetics of artesunate and amodiaquine in African children.

Stepniewska K, Taylor W, Sirima SB, Ouedraogo EB, Ouedraogo A, Gansané A, Simpson JA, Morgan CC, White NJ, Kiechel JR.

Malar J. 2009 Aug 20;8:200. doi: 10.1186/1475-2875-8-200.

13.

Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers.

Orrell C, Little F, Smith P, Folb P, Taylor W, Olliaro P, Barnes KI.

Eur J Clin Pharmacol. 2008 Jul;64(7):683-90. doi: 10.1007/s00228-007-0452-8. Epub 2008 Apr 16.

14.

Pharmacokinetics of artesunate alone and in combination with sulfadoxine/pyrimethamine in healthy Sudanese volunteers.

Matar KM, Awad AI, Elamin SB.

Am J Trop Med Hyg. 2014 Jun;90(6):1087-93. doi: 10.4269/ajtmh.13-0283. Epub 2014 Mar 10.

15.

Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers.

Morris CA, Lopez-Lazaro L, Jung D, Methaneethorn J, Duparc S, Borghini-Fuhrer I, Pokorny R, Shin CS, Fleckenstein L.

Am J Trop Med Hyg. 2012 Mar;86(3):489-95. doi: 10.4269/ajtmh.2012.11-0558.

16.

Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.

Jittamala P, Pukrittayakamee S, Ashley EA, Nosten F, Hanboonkunupakarn B, Lee SJ, Thana P, Chairat K, Blessborn D, Panapipat S, White NJ, Day NP, Tarning J.

Antimicrob Agents Chemother. 2015 Jan;59(1):505-13. doi: 10.1128/AAC.03829-14. Epub 2014 Nov 10.

17.

Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.

Fortin A, Verbeeck RK, Jansen FH.

Eur J Clin Pharmacol. 2011 Mar;67(3):267-75. doi: 10.1007/s00228-010-0911-5. Epub 2010 Oct 15.

PMID:
20949263
18.

Pharmacokinetic properties of azithromycin in pregnancy.

Salman S, Rogerson SJ, Kose K, Griffin S, Gomorai S, Baiwog F, Winmai J, Kandai J, Karunajeewa HA, O'Halloran SJ, Siba P, Ilett KF, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2010 Jan;54(1):360-6. doi: 10.1128/AAC.00771-09. Epub 2009 Oct 26.

19.

Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration.

Diem Thuy LT, Ngoc Hung L, Danh PT, Na-Bangchang K.

Eur J Clin Pharmacol. 2008 Oct;64(10):993-8. doi: 10.1007/s00228-008-0506-6. Epub 2008 Jul 4.

PMID:
18600318
20.

Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects.

Chinh NT, Quang NN, Thanh NX, Dai B, Geue JP, Addison RS, Travers T, Edstein MD.

Antimicrob Agents Chemother. 2009 Feb;53(2):828-31. doi: 10.1128/AAC.00927-08. Epub 2008 Dec 1.

Supplemental Content

Support Center